A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
PF-03893787, a novel anti-inflammatory agent should attenuate the effect of a bronchial
allergen challenge on lung function and hence provide proof of mechanism for this agent.